Press release
Investigation announced for Investors of PRA Health Sciences, Inc. (NASDAQ: PRAH) over Takeover
An investigation on behalf of investors of PRA Health Sciences, Inc. (NASDAQ: PRAH) in connection with the proposed takeover.
is unfair to NASDAQ: PRAH stockholders.
Investors who purchased shares of PRA Health Sciences, Inc. (NASDAQ: PRAH) and currently hold any of those NASDAQ: PRAH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of PRA Health Sciences, Inc. breached their fiduciary duties owed to NASDAQ: PRAH investors in connection with the proposed acquisition.
Raleigh, NC based PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. On Feb. 24, 2021, ICON plc, (NASDAQ: ICLR) announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a cash and stock transaction valued at approximately $12 billion, with the per share merger consideration consisting of $80 in cash and 0.4125 shares of ICON stock. Based on a closing price of $208.62 per NASDAQ: ICLR share on February 23, 201, investors in PRA Health Sciences, Inc. (NASDAQ: PRAH) will received a value of approximately of $166.06 per NASDAQ: PRAH shares.
However, given that at least one analyst has set the high target price of NASDAQ: PRAH shares at $196 per share, the investigation concerns whether the offer is unfair to NASDAQ: PRAH stockholders. More specifically, the investigation concerns whether the PRA Health Sciences Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Those who are current investors in PRA Health Sciences, Inc. (NASDAQ: PRAH) shares have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors of PRA Health Sciences, Inc. (NASDAQ: PRAH) over Takeover here
News-ID: 2259488 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for PRA
PRA Public Relations Recognized as Top PR Agency With Multiple Industry Honors
Why was PRA Public Relations Recognized as a National Top Tech PR Agency? CEO Pam Abrahamsson Cites a Relentless Dedication to Client Success
PRA Public Relations [http://www.prapublicrelations.com/], a national PR agency serving the technology, financial services, and social impact sectors, has announced it was recently recognized with a series of industry honors for its industry knowledge, business-driving results and 'client first' focus.
Awards Recognizing PRA Public Relations as a Leading PR Agency…
Lawsuit filed for Investors in shares of ProAssurance Corporation (NYSE: PRA)
An investor, who purchased shares of ProAssurance Corporation (NYSE: PRA), filed a lawsuit over alleged Securities Laws violations by ProAssurance Corporation.
Investors who purchased shares of ProAssurance Corporation (NYSE: PRA) have certain options and for certain investors are short and strict deadlines running. Deadline: August 17, 2020. NYSE: PRA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Birmingham, AL based ProAssurance Corporation, through its subsidiaries, provides…
Investigation for Investors in shares of ProAssurance Corporation (NYSE: PRA) an …
An investigation was announced concerning potential securities laws violations by ProAssurance Corporation in connection with certain financial statements.
Investors who purchased shares of ProAssurance Corporation (NYSE: PRA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by ProAssurance Corporation regarding its business, its prospects and its operations were materially false and…
Clinical Trial Services Market Growing Demand 2019 - Parexel, PRA, PPD, Labcorp, …
Clinical Trial Services Market Research Report Formulates with historic data up to 2019 and gives a forecast for 2019-2024. The report gives a comprehensive outlook of the market including the current market status, historic, and expected way forward for the global Clinical Trial Services market. The report inspects market size, key trends, technologies, challenges, product scope, industry revenue, and growth opportunities. The report delivers data on the drivers and restraints…
Investigation announced for Investors in shares of ProAssurance Corporation (NYS …
An investigation was announced concerning possible securities laws violations by ProAssurance Corporation in connection with certain financial statements.
Investors who purchased shares of ProAssurance Corporation (NYSE: PRA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by ProAssurance Corporation regarding its business, its prospects and its operations were materially false and…
Preclinical CRO Market Emerging Growth Analysis, Business Opportunities and Majo …
Preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the…
